Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Levorphanol for Excruciating Pain from Oral Cancer: A Case Report

Author(s):  McNulty Jack P

Issue:  May/Jun 2007 - Pain Management
View All Articles in Issue

Abstract:  In the United States, the most common cancers of the head and neck are those of the oral cavity and pharynx. In 2007, oral cancer will be diagnosed in more than 37,000 Americans and will claim more than 7,500 lives. The report presented here describes a case of extraordinary pain in a woman with metastatic adenocarcinoma of the hard palate. At the time of her referral for hospice care, she was experiencing excruciating, unremitting, chronic pain graded 10 of 10 on a standard pain scale. Her analgesic treatment consisted of opioids prescribed in increasingly higher doses until they were ineffective, the effects of treatment could not be tolerated, or she could not swallow the quantity of oral medication needed to provide relief. Only the opioid levorphanol has provided effective analgesia with few adverse effects, and the patient’s malignant pain is manageable with far fewer doses of oral medication. Comments from the patient’s physician, the pain management specialist who provided the successful conversion be

Related Keywords: Jack P. McNulty, MD, FACP, FAAHPM, levorphanol, N-methyl-D-aspartate receptor antagonist, NMDA blocker, oral cancer, pain control, pain management, case report, analgesia, analgesics, adverse effects, side effects, supportive care, opioid conversion

Related Categories: CANCER AND AIDS, EAR NOSE THROAT, FORMULATIONS, PAIN MANAGEMENT, CASE REPORTS, NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report McNulty Jack P May/Jun 2007 212-218 Buy
Levorphanol for the Treatment of Severe Chronic Pain McNulty Jack P May/Jun 2007 202-211 Buy
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol McNulty Jack P Mar/Apr 2006 159-160 Buy
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi Jul/Aug 2015 295-300 Buy
Update on Managing Neuropathic Pain McNulty Jack P, Muller George May/Jun 2009 182-190 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III May/Jun 2010 182-192 Buy
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report McNulty Jack P, Hahn Kristian Sep/Oct 2012 364-368 Buy
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Zur Eyal Jan/Feb 2014 14-19 Buy
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Vail Jane May/Jun 2007 187-192 Buy